Cutler Group LP Puma Biotechnology, Inc. Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$9.38 - $13.63 $5,628 - $8,178	-600 Reduced 75.0%	200 $1,000
Q3 2020 Oct 27, 2020	BUY	$9.5 - $11.14 $1,900 - $2,228	200 Added 33.33%	800 $8,000
Q2 2020 Jul 22, 2020	SELL	$7.01 - $13.24 $10,164 - $19,198	-1,450 Reduced 70.73%	600 $6,000
Q1 2020 May 07, 2020	BUY	$6.28 - $14.57 $4,710 - $10,927	750 Added 57.69%	2,050 $17,000
Q4 2019 Feb 06, 2020	BUY	$6.5 - $10.73 $1,950 - $3,219	300 Added 30.0%	1,300 $11,000
Q3 2019 Oct 28, 2019	SELL	$8.75 - $12.85 $39,375 - $57,825	-4,500 Reduced 81.82%	1,000 $10,000
Q2 2019 Aug 09, 2019	BUY	$12.3 - $35.76 $21,156 - $61,507	1,720 Added 45.5%	5,500 $69,000
Q1 2019 May 10, 2019	SELL	$20.77 - $42.37 $8,245 - $16,820	-397 Reduced 9.5%	3,780 $146,000
Q4 2018 Feb 05, 2019	SELL	$20.07 - $46.7 $302,535 - $703,955	-15,074 Reduced 78.3%	4,177 $85,000
Q3 2018 Nov 07, 2018	BUY	$41.2 - $59.85 $156,724 - $227,669	3,804 Added 24.63%	19,251 $882,000
Q2 2018 Aug 10, 2018	BUY	$48.3 - $68.25 $522,122 - $737,782	10,810 Added 233.12%	15,447 $913,000
Q1 2018 May 11, 2018	SELL	$59.7 - $99.25 $997,169 - $1.66 Million	-16,703 Reduced 78.27%	4,637 $315,000
Q4 2017 Jan 17, 2018	BUY	$93.85 - $132.45 $916,351 - $1.29 Million	9,764 Added 84.35%	21,340 $2.11 Million
Q3 2017 Oct 17, 2017	BUY	$72.0 - $119.75 $833,472 - $1.39 Million	11,576	11,576 $1.39 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.